Merck
CN

21118

Sigma-Aldrich

柠檬酸三钙 四水合物

BioUltra, ≥98.0% (calc. on dry substance, KT)

登录查看公司和协议定价

别名:
柠檬酸 钙盐, 柠檬酸钙
线性分子式:
Ca3(C6H5O7)2 · 4H2O
CAS号:
分子量:
570.49
Beilstein:
3924520
EC 号:
MDL编号:
PubChem化学物质编号:
NACRES:
NA.25

产品线

BioUltra

检测方案

≥98.0% (calc. on dry substance, KT)

形式

powder

杂质

Insoluble matter, passes filter test

缺失

10-14% loss on drying, 180°C, 4 h

溶解性

0.1 M HCl: 0.01 M at 20 °C, clear, colorless

痕量阴离子

chloride (Cl-): ≤50 mg/kg
sulfate (SO42-): ≤100 mg/kg

痕量阳离子

As: ≤0.1 mg/kg
Ba: ≤5 mg/kg
Bi: ≤5 mg/kg
Cd: ≤5 mg/kg
Co: ≤5 mg/kg
Cr: ≤5 mg/kg
Cu: ≤5 mg/kg
Fe: ≤50 mg/kg
Hg: ≤0.1 mg/kg
K: ≤500 mg/kg
Li: ≤5 mg/kg
Mg: ≤1000 mg/kg
Mn: ≤50 mg/kg
Mo: ≤5 mg/kg
Na: ≤100 mg/kg
Ni: ≤5 mg/kg
Pb: ≤1 mg/kg
Sr: ≤100 mg/kg
Zn: ≤5 mg/kg

λ

0.01 M in 0.1 M HCl

紫外吸收

λ: 260 nm Amax: 0.04
λ: 280 nm Amax: 0.03

SMILES字符串

O.O.O.O.OC1(CC(=O)O[Ca]OC(=O)C1)C(=O)O[Ca]OC(=O)C2(O)CC(=O)O[Ca]OC(=O)C2

InChI

1S/2C6H8O7.3Ca.4H2O/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;4*1H2/q;;3*+2;;;;/p-6

InChI key

LNIZKKFWMDARJV-UHFFFAOYSA-H

正在寻找类似产品? Visit 产品对比指南

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

为方便起见,与您过往购买产品相关的文件已保存在文档库中。

访问文档库

难以找到您所需的产品或批次号码?

在网站页面上,产品编号会附带包装尺寸/数量一起显示(例如:T1503-25G)。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题?欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ (Lot或Batch)字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等,请输入去除前两位字母的批号:09019TO。

  • 如果您查询到的批号含有填充代码(例如05427ES-021),请输入去除填充代码-021的批号:05427ES。

  • 如果您查询到的批号含有填充代码(例如 STBB0728K9),请输入去除填充代码K9的批号:STBB0728。

未找到您寻找的产品?

部分情况下,可能未在线提供COA。如果搜索不到COA,可在线索取。

索取COA

Xin Zhou et al.
American journal of hypertension, 22(9), 934-942 (2009-08-08)
Salt restriction, an important approach for primary and secondary prevention of hypertension, is undermined by unsatisfactory adherence. A salt-restriction study tested the efficacy and safety of a compound ion salt (CISalt) with low sodium content in an animal model and
Jochen Klaus et al.
Journal of gastrointestinal and liver diseases : JGLD, 20(2), 141-148 (2011-07-05)
Osteoporosis commonly afflicts Crohn's disease (CD) patients. Management remains unclear, with limited results for intravenous (i.v.) bisphosphonates and a follow-up longer than one year. Intravenous bisphosphonates bypass gastrointestinal-tract irritation offering an interesting alternative suitable for CD patients. We tested the
J Christopher Gallagher et al.
The Journal of clinical endocrinology and metabolism, 97(10), 3550-3556 (2012-08-03)
Vitamin D is often recommended for use with calcium supplements to increase absorption. There are no systematic studies of vitamin D on calcium absorption that indicate what dose should be recommended. Our objective was to study the effect of increasing
Sherry Huang et al.
Nanotechnology, 20(37), 375102-375102 (2009-08-27)
Taking calcium supplements can reduce the risk of developing osteoporosis, but they are not readily absorbed in the gastrointestinal tract. Nanotechnology is expected to resolve this problem. In the present study, we examined whether the bioavailability of calcium carbonate and
Wei Zhang et al.
Asian Pacific journal of tropical medicine, 5(4), 310-314 (2012-03-28)
To explore effect of calcium citrate on bone integration in a rabbit femur defect model, and to compare the bone formation with different sizes by radiological and histological study. Twenty-four male Japanese white rabbits were randomly divided into three groups

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门